Type 1 Diabetes

Type 1 also known as juvenile diabetes and occurs when the body fails to produce insulin. People with Type 1 diabetes are insulin-dependent, which means they must take artificial insulin daily to stay alive otherwise some other rare forms of diabetes would be directly inherited. That includes Maturity Onset Diabetes in the Young (MODY), and diabetes due to mutations in mitochondrial DNA. In addition to the consequences of abnormal metabolism of glucose it can cause hyperlipidaemia, glycosylation of proteins. Type1 Diabetes is caused by the autoimmune destruction of the beta cells of the pancreas and represents approximately 10.5% of all cases with diabetes. Generally lifelong insulin therapy is the only treatment for this disorder. Without exogenous insulin injections, individuals with Type1 Diabetes will not survive.                      

 

  • Genetic studies on Type1 and Type 2 Diabetes
  • The value of monogenic subtypes of diabetes
  • Factors contributing to the complexity of analysis
  • DNA diagnostics and pharmacogenetics in clinical trials

Related Conference of Type 1 Diabetes

March 25-26, 2024

5th Annual Conference on Diabetes

London, UK
July 11-12, 2024

7th Annual Meeting on Diabetes and Endocrinology

Paris, France
September 09-10, 2024

4th European Endocrinology and Diabetes Congress

Paris, France
November 22-23, 2024

20th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands

Type 1 Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in